Olema is a clinical-stage biopharmaceutical company focused on transforming the metastatic breast cancer treatment paradigm and improving outcomes for patients living with breast cancer and beyond
Olema is a clinical-stage biopharmaceutical company focused on transforming the metastatic breast cancer treatment paradigm and improving outcomes for patients living with breast cancer and beyond. They are advancing their pipeline of novel therapies by leveraging their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance.